Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• Radiation safety action plan recommendations: Maximize benefits, minimize risk
• Let's not be so quick to stop statins Roger S. Blumenthal, MD; Seth S. Martin, MD, MHS, FACC, FAHA, FASPC; Michael J. Blaha, MD, MPH
• ACCF, AHA and HRS update CRT guidelines
• Burnout burden high among US physicians
• Children with congenital heart disease at increased risk for developmental disorders
• Duration of resuscitation attempts varies between US hospitals
• Galectin-3 may serve as predictor of HF
• Guidelines issued for evaluation, treatment of hypertriglyceridemia
• Long-term symptoms of restless legs syndrome linked to CHD
• Markers identified for improved assessment of intermediate CV risk
• NIH trial to examine use of methotrexate for prevention of CVD
• THESUS-HF study reveals trends in acute HF in Africa
• Unrecognized MI more common, dangerous in older adults than previously suspected
• Advisory panel not in favor of new hyponatremia drug approval
• Committee advises against approval of phenylephrine in acute hypotensive states
• Cryoballoon wins FDA approval, CE mark for paroxysmal AF
• Generic version of pioglitazone receives FDA approval
• FDA recommends imaging for patients implanted with Riata leads
• FDA: Sildenafil should not be used in children with pulmonary hypertension
• Genetic predisposition linked to coronary calcification Robert Roberts, MD, FRSC, FRCPC, MACC, LLD (Hon.), FAHA; Brandon A. Roberts, MSc, MD; Calvin W. Roberts, MD; William L. Roberts, MHA, CPA
• New public-private partnership fights fraud through information sharing Kirk Ogrosky, JD; John St. Leger, JD
• Active telephone follow-up reduced mortality in chronic HF patients
• Adolescents with metabolic syndrome displayed lower overall intelligence
• Black stroke survivors face greater risk from high BP
• Blood clot removal device shows potential for patients with ischemic stroke
• Cerebral microembolization likely in all cases of TAVR
• Common chemicals found in paper, lubricant products increased risk for CVD, PAD
• Discrepancy in mortality found for patients with diabetes treated with clopidogrel
• Door-to-activation times drove overall door-to-balloon times
• Drug use for management of mild hypertension called into question
• Early aggressive treatment failed to benefit elderly patients with non-ST-elevation ACS
• HERCULES: Renal stenting appears promising for patients with uncontrolled hypertension
• Job strain linked to increased CHD risk in large European study
• No significant differences noted among new oral anticoagulants for stroke prevention in AF
• Spouses face increased risk for mental issues after partner's AMI
• Statin therapy associated with reduced risk for pancreatitis
• Transcatheter valve shown feasible in first-in-human use
• Trastuzumab linked to elevated risk for HF, cardiomyopathy
• Type A personality and stress linked to high risk for stroke
• ACCESS-EUROPE: Percutaneous treatment of MR validated in real-world setting
• ALKK-PCI registry: Women less likely to receive DES than men
• Central obesity increased risk for CV, all-cause death despite normal BMI
• WOEST: Less bleeding risk with dual therapy
• CORE320: Noninvasive imaging strategy helped identify flow-limiting CAD
• CRT consensus set to standardize and improve patient care
• DeFACTO: FFR-CT a novel method for determining lesion-specific ischemia
• Energy drink consumption improved cardiac function
• FAME II: Positive results upheld for FFR-guided PCI plus medical therapy
• FAST-MI program highlights risk factors for STEMI
• Hospital readmission frequent after continuous flow pump therapy
• IABP-SHOCK II: IABP failed to reduce 30-day mortality in patients with cardiogenic shock
• Micropump-based device enhanced outcomes, exercise tolerance, quality of life
• New compound improved HF symptoms in patients with CKD
• PARAMOUNT: Investigational drug shows promising results
• Partitioning device linked to positive long-term HF outcomes
• Societies publish third universal definition of MI
• Stopping antiplatelet therapy increases mortality risk after cardiac surgery for TKA patients
• Study links depression treatment to better outcomes in HF patients
• WOEST: Less bleeding risk with dual therapy
• Ambulatory BP monitoring to guide pharmacotherapy for hypertension Michael Brenner, PharmD, BCPS
• ARREST
• DeFACTO
• FAME II
• ORIGIN-GRACE
• PARAMOUNT
• PROTECT
• PURE
• WOEST